EUVIMEDEUVIMED entdecken
Crossref

Recombinant Expression and Engineering of MDI- and HDI-Specific Monoclonal Antibodies for Proof-of-Concept Detection of Diisocyanate Adducts and Candidate Assay Calibrators

Adam V Wisnewski iD, Jian Liu, Carrie A Redlich

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy · 2026

DOI: 10.1177/21679436261483330 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 2026. Verfasst von Adam V Wisnewski und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yale University, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Cyanates, Isocyanates. Die Arbeit nennt 37 Literaturangaben. Gefördert von: National Institute for Occupational Safety and Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methylene-diphenyl diisocyanate (MDI) and hexamethylene diisocyanate (HDI), important chemicals for polyurethane production, can react with self-molecules, trigger immune responses, and cause asthma. To validate molecular determinants of diisocyanate immune recognition and develop renewable immunoassay reagents, we generated MDI- and HDI-specific recombinant monoclonal antibodies (mAbs) from hybridoma-derived variable-region DNA sequences using a human embryonic kidney (HEK) cell line expression system. Three anti-MDI and one anti-HDI mouse IgG1/κ mAbs were produced, purified, and evaluated for binding to MDI, HDI, and control antigens, including toluene diisocyanate (TDI) and mock-reacted protein. To support assay standardization in research and translational applications, we engineered one anti-MDI (DA5) and one anti-HDI (AG5) mAb as human Fc chimeras (human IgG1 or IgE heavy-chain constant regions with human κ light-chain constant region) and confirmed that chimerization preserved antigen specificity. As a proof-of-principle, one of the chimeric mAbs was evaluated as a candidate calibrator in an enzyme-linked immunosorbant assay (ELISA) format to quantify diisocyanate-specific antibodies in serum from an MDI-exposed worker. In addition, mAb DA5 was engineered with a FLAG epitope to enable immunoassays for detecting MDI–protein reaction products in airway fluid, including sandwich ELISA (with anti-MDI mAb CE2) and Western blot formats. Together, these data show that diisocyanate specificity can be recapitulated by recombinant expression from deposited variable-region DNA sequences. The engineered reagents enable immunoassay detection of MDI–protein adducts in complex matrices and serve as proof-of-concept calibrators for ELISA-based quantification of anti-diisocyanate antibodies in human serum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalCyanatesIsocyanatesHumansAnimalsHEK293 CellsMiceEnzyme-Linked Immunosorbent AssayImmunoglobulin GRecombinant ProteinsProtein EngineeringHybridomasAntibody SpecificityBenzhydryl Compounds

Stichwörter der Autor:innen

chemicalexposurehexamethylene diisocyanatemethylene-diphenyl diisocyanate

Substanzen

Antibodies, Monoclonal1,6-hexamethylene diisocyanateCyanates4,4'-diphenylmethane diisocyanateIsocyanatesImmunoglobulin GRecombinant ProteinsBenzhydryl Compounds

Autor:innen und Institutionen

  • Department of Internal Medicine, Yale University, New Haven, Connecticut, USA.

ORCID-Profile: Adam V Wisnewski

Förderung

  • National Institute for Occupational Safety and Health

Zitieren

APA

Wisnewski, A. V., Liu, J., & Redlich, C. A. (2026). Recombinant Expression and Engineering of MDI- and HDI-Specific Monoclonal Antibodies for Proof-of-Concept Detection of Diisocyanate Adducts and Candidate Assay Calibrators. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. https://doi.org/10.1177/21679436261483330

Vancouver

Wisnewski AV, Liu J, Redlich CA. Recombinant Expression and Engineering of MDI- and HDI-Specific Monoclonal Antibodies for Proof-of-Concept Detection of Diisocyanate Adducts and Candidate Assay Calibrators. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. 2026. doi:10.1177/21679436261483330

BibTeX
@article{Wisnewski2026,
  author = {Wisnewski, Adam V and Liu, Jian and Redlich, Carrie A},
  title = {Recombinant Expression and Engineering of MDI- and HDI-Specific Monoclonal Antibodies for Proof-of-Concept Detection of Diisocyanate Adducts and Candidate Assay Calibrators},
  journal = {Monoclonal Antibodies in Immunodiagnosis & Immunotherapy},
  year = {2026},
  doi = {10.1177/21679436261483330}
}
Kostenlos starten →